1. Home
  2. SRDX vs MFH Comparison

SRDX vs MFH Comparison

Compare SRDX & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • MFH
  • Stock Information
  • Founded
  • SRDX 1979
  • MFH 2011
  • Country
  • SRDX United States
  • MFH United States
  • Employees
  • SRDX N/A
  • MFH N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • MFH Finance: Consumer Services
  • Sector
  • SRDX Health Care
  • MFH Finance
  • Exchange
  • SRDX Nasdaq
  • MFH Nasdaq
  • Market Cap
  • SRDX 416.3M
  • MFH 386.1M
  • IPO Year
  • SRDX 1998
  • MFH N/A
  • Fundamental
  • Price
  • SRDX $28.87
  • MFH $31.90
  • Analyst Decision
  • SRDX Buy
  • MFH
  • Analyst Count
  • SRDX 3
  • MFH 0
  • Target Price
  • SRDX $43.00
  • MFH N/A
  • AVG Volume (30 Days)
  • SRDX 138.2K
  • MFH 441.4K
  • Earning Date
  • SRDX 11-05-2025
  • MFH 04-30-2025
  • Dividend Yield
  • SRDX N/A
  • MFH N/A
  • EPS Growth
  • SRDX N/A
  • MFH N/A
  • EPS
  • SRDX N/A
  • MFH N/A
  • Revenue
  • SRDX $120,801,000.00
  • MFH N/A
  • Revenue This Year
  • SRDX N/A
  • MFH N/A
  • Revenue Next Year
  • SRDX $3.38
  • MFH N/A
  • P/E Ratio
  • SRDX N/A
  • MFH N/A
  • Revenue Growth
  • SRDX N/A
  • MFH 125.92
  • 52 Week Low
  • SRDX $26.00
  • MFH $1.03
  • 52 Week High
  • SRDX $40.39
  • MFH $36.77
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 25.36
  • MFH 74.08
  • Support Level
  • SRDX $29.54
  • MFH $16.69
  • Resistance Level
  • SRDX $30.19
  • MFH $36.77
  • Average True Range (ATR)
  • SRDX 0.74
  • MFH 4.70
  • MACD
  • SRDX -0.21
  • MFH 1.96
  • Stochastic Oscillator
  • SRDX 6.26
  • MFH 83.42

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About MFH Mercurity Fintech Holding Inc.

Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.

Share on Social Networks: